Document Detail

The influence of prenatal dexamethasone treatment on urinary excretion of adrenocortical steroids in newborns.
MedLine Citation:
PMID:  9686811     Owner:  NLM     Status:  MEDLINE    
CONCLUSIONS: Heterogeneity in the fetal adrenal response to maternal dexamethasone treatment was confirmed. Suppression of fetal adrenals, especially within the fetal adrenal zone, can be observed in some babies born healthy until at least 1 week after birth.
E M Małunowicz; M Ginalska-Malinowska; T E Romer; K Bal
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  European journal of pediatrics     Volume:  157     ISSN:  0340-6199     ISO Abbreviation:  Eur. J. Pediatr.     Publication Date:  1998 Jul 
Date Detail:
Created Date:  1998-09-22     Completed Date:  1998-09-22     Revised Date:  2013-05-20    
Medline Journal Info:
Nlm Unique ID:  7603873     Medline TA:  Eur J Pediatr     Country:  GERMANY    
Other Details:
Languages:  eng     Pagination:  539-43     Citation Subset:  IM    
Department of Laboratory Diagnostics, The Children's Memorial Health Institute, Warsaw, Poland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adrenal Hyperplasia, Congenital* / prevention & control*
Dexamethasone / therapeutic use*
Fetal Diseases / drug therapy*
Glucocorticoids / therapeutic use*
Hydroxycorticosteroids / urine*
Infant, Newborn
Reg. No./Substance:
0/Glucocorticoids; 0/Hydroxycorticosteroids; 50-02-2/Dexamethasone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Cardiovascular changes in children with mucopolysaccharide storage diseases and related disorders--c...
Next Document:  A patient with congenital lipoid adrenal hyperplasia evaluated by serial abdominal ultrasonography.